What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Ruminant Mastitis: Diagnosis, Treatment, and Control

Mastitis in ruminants is an inflammation of the mammary gland, most often caused by bacterial infection, that reduces milk yield, alters milk composition, and compromises animal welfare. This article provides veterinarians and dairy producers with diagnostic approaches, pathogen-specific treatment considerations, and herd-level control measures applicable to cattle, sheep, and goats. The content draws on peer-reviewed evidence and official veterinary references to support clinical decision-making.

At a Glance

Aspect	Bovine Mastitis	Ovine Mastitis	Caprine Mastitis
Primary pathogens	Staphylococcus aureus, Streptococcus agalactiae, Escherichia coli, Mycoplasma spp.	Staphylococcus aureus, Mannheimia haemolytica, Streptococcus spp.	Staphylococcus aureus, non-aureus staphylococci, Mycoplasma spp.
Clinical signs	Swollen, hot, painful quarter, abnormal milk, systemic signs in severe cases	Hard, swollen udder half, gangrenous mastitis common, high fever	Firm, warm udder, milk clots, subclinical infections frequent
Diagnostic method	CMT, SCC, bacteriological culture, PCR	CMT, bacteriological culture	CMT, SCC, bacteriological culture
Treatment approach	Intramammary antibiotics, systemic antibiotics for severe cases, NSAIDs	Systemic antibiotics, intramammary therapy, supportive care	Intramammary antibiotics, systemic therapy for severe cases
Control emphasis	Milking hygiene, dry cow therapy, culling chronic cases	Hygiene, lamb management, culling	Milking hygiene, culling chronic carriers, vaccination where available

Clinical and Subclinical Mastitis: Definitions and Diagnostic Distinctions

Clinical mastitis presents with visible abnormalities in the udder or milk. The affected quarter may be swollen, firm, hot, and painful. Milk appears watery, contains clots, flakes, or blood. Systemic signs such as fever, depression, anorexia, and dehydration indicate severe infection. The Merck Veterinary Manual provides detailed descriptions of clinical mastitis presentations across ruminant species.

Subclinical mastitis shows no visible udder or milk changes but is detected through diagnostic testing. Elevated somatic cell counts (SCC) and positive bacteriological culture confirm infection. Subclinical infections reduce milk production and quality and serve as reservoirs for pathogen transmission within the herd.

The California Mastitis Test (CMT) provides a rapid, cow-side screening method for subclinical mastitis. A positive CMT reaction indicates elevated SCC and warrants further investigation through bacteriological culture. The World Organisation for Animal Health (WOAH) includes mastitis surveillance as part of its animal health and welfare standards, emphasizing the importance of early detection.

Pathogen-Specific Diagnosis and Treatment Considerations

Gram-Positive Pathogens

Staphylococcus aureus causes chronic, contagious mastitis that responds poorly to treatment. Intramammary infection leads to microabscess formation within the mammary parenchyma, limiting antibiotic penetration. Bacteriological culture confirms the pathogen. Treatment success rates remain low, and culling chronically infected animals is often the most effective control measure.

Streptococcus agalactiae is an obligate intramammary pathogen that responds well to intramammary antibiotic therapy. Herd-level eradication is achievable through blanket dry cow therapy and milking time hygiene. Regular bacteriological monitoring confirms elimination.

Non-aureus staphylococci (NAS), including Staphylococcus epidermidis, are common in goats and heifers. These pathogens cause mild to moderate subclinical infections. A 2025 study in Small Ruminant Research evaluated two long-acting intramammary antimicrobials for curing subclinical mastitis due to non-aureus staphylococci in dairy goats. Treatment decisions should consider cure rates and withdrawal periods.

Gram-Negative Pathogens

Escherichia coli causes acute, often severe clinical mastitis in cattle. Endotoxin release triggers systemic inflammation, including fever, shock, and death in severe cases. Treatment focuses on supportive care: fluid therapy, non-steroidal anti-inflammatory drugs (NSAIDs), and frequent milk-out. Systemic antibiotics are indicated when signs of sepsis are present.

Mannheimia haemolytica is a common cause of gangrenous mastitis in sheep. The infection progresses rapidly, with necrosis of the affected udder half. Systemic antibiotics and supportive care are essential. Prognosis is guarded, and culling is often necessary.

Mycoplasma Species

Mycoplasma bovis and other Mycoplasma species cause contagious mastitis that does not respond to conventional antibiotics. Diagnosis requires specialized culture media or PCR. Control relies on biosecurity, segregation of infected animals, and culling. No effective treatment exists for mycoplasmal mastitis.

Diagnostic Workflow for Clinical Mastitis

Step 1: Clinical Examination and Sample Collection

Examine the udder for swelling, heat, pain, and asymmetry. Collect a milk sample aseptically from the affected quarter before any treatment. Label the sample with animal identification, quarter, and date. Refrigerate and transport to a diagnostic laboratory within 24 hours.

Step 2: Bacteriological Culture and Sensitivity Testing

Culture identifies the causative pathogen. Antimicrobial susceptibility testing guides antibiotic selection. A 2011 multispecies review in the Journal of Mammary Gland Biology and Neoplasia emphasized that susceptibility patterns vary by pathogen, region, and farm. Routine susceptibility testing supports responsible antimicrobial use.

Step 3: Somatic Cell Count Monitoring

SCC is a key indicator of udder health. Individual cow SCC above 200,000 cells/mL suggests subclinical mastitis. Bulk tank SCC above 400,000 cells/mL indicates herd-level problems. Regular SCC monitoring tracks treatment efficacy and identifies chronic carriers.

Step 4: Record Keeping

Maintain individual animal records for each mastitis case. Record date, quarter affected, clinical severity, pathogen identified, treatment administered, and outcome. These records inform culling decisions and herd-level control strategies.

Treatment Protocols for Bovine Mastitis

Intramammary Antibiotic Therapy

Intramammary antibiotics are the standard treatment for uncomplicated clinical mastitis in lactating dairy cattle. Selection depends on the pathogen and susceptibility results. A 2019 systematic review and network meta-analysis in Animal Health Research Reviews compared the efficacy of antimicrobials for treatment of clinical mastitis in lactating dairy cattle. The review found variability in cure rates among different antimicrobial classes.

Treatment duration typically ranges from two to five days. Extended therapy may be indicated for chronic or refractory infections. Always follow label instructions for dosage, frequency, and milk withdrawal periods.

Systemic Antibiotic Therapy

Systemic antibiotics are indicated for severe clinical mastitis with systemic signs. A 2024 scoping review in Frontiers in Veterinary Science examined treatment of clinically severe bovine mastitis. The review highlighted the need for standardized protocols and further research on optimal systemic antibiotic regimens.

Common systemic antibiotics include ceftiofur, florfenicol, and oxytetracycline. Selection should be based on susceptibility testing and regulatory approval. Combination therapy with intramammary and systemic antibiotics may be considered in severe cases.

Supportive Care

Supportive care improves outcomes in severe mastitis. Frequent milk-out (every 2-4 hours) removes bacteria and endotoxins from the udder. NSAIDs reduce inflammation, fever, and pain. Fluid therapy corrects dehydration and electrolyte imbalances. In cases of endotoxic shock, intravenous fluids and anti-inflammatory drugs are critical.

Non-Antibiotic Treatment Options

A 2018 randomized controlled trial in The Veterinary Record compared individualized homeopathy and antibiotics in the treatment of bovine clinical mastitis. The study found that antibiotics were more effective than homeopathy for clinical cure. Evidence does not support homeopathy as a substitute for antibiotic therapy in clinical mastitis.

Alternative treatments such as herbal preparations, probiotics, and immunomodulators have been investigated but lack robust clinical trial data. The 2025 review in Small Ruminant Research on conventional and alternative treatment of mastitis in dairy goats noted that alternative therapies may have a role in mild cases but should not replace proven antimicrobial therapy in severe infections.

Treatment Protocols for Ovine Mastitis

Ovine mastitis is often acute and severe. Mannheimia haemolytica and Staphylococcus aureus are the most common pathogens. Treatment must be initiated promptly to prevent gangrene and death.

Systemic Antibiotics

Systemic antibiotics are the primary treatment for ovine mastitis. Oxytetracycline, ceftiofur, and penicillin-streptomycin combinations are commonly used. Selection should be based on culture and sensitivity results. Treatment duration is typically 3-5 days.

Intramammary Therapy

Intramammary tubes designed for cattle can be used in sheep, but the smaller teat canal requires careful insertion. Use only products labeled for lactating animals. Withdrawal periods for milk and meat must be observed.

Supportive Care

Frequent milk-out, NSAIDs, and fluid therapy are essential. Gangrenous mastitis requires surgical debridement or amputation of the affected udder half. Prognosis is poor, and culling is often recommended.

Treatment Protocols for Caprine Mastitis

Goat mastitis presents unique challenges. Subclinical infections are common, and SCC thresholds differ from cattle. A SCC above 1,000,000 cells/mL in goats suggests infection.

Intramammary Antibiotic Therapy

Intramammary antibiotics are effective for subclinical and mild clinical mastitis in goats. A 2025 study in Small Ruminant Research evaluated two long-acting intramammary antimicrobials for curing subclinical mastitis due to non-aureus staphylococci in dairy goats. Cure rates varied by product and pathogen.

Systemic Antibiotic Therapy

Systemic antibiotics are indicated for severe clinical mastitis. Ceftiofur, oxytetracycline, and florfenicol are commonly used. A 2016 case-control study in Preventive Veterinary Medicine examined risk factors and therapy for goat mastitis in Bangladesh. The study identified poor hygiene and lack of veterinary care as major risk factors.

Supportive Care

Frequent milk-out, NSAIDs, and fluid therapy are important. Goats are prone to metabolic complications such as ketosis during mastitis. Monitor appetite and milk production closely.

Herd-Level Control Measures

Milking Hygiene

Proper milking hygiene reduces new infections. Pre-milking teat dipping with an effective disinfectant kills bacteria on the teat skin. Post-milking teat dipping seals the teat canal and prevents bacterial entry. Use separate towels for each cow to prevent cross-contamination.

Dry Cow Therapy

Dry cow therapy eliminates existing infections and prevents new infections during the dry period. Blanket dry cow therapy treats all quarters of all cows at drying off. Selective dry cow therapy treats only infected quarters based on SCC and culture results. Both approaches have evidence supporting their use.

Culling Chronically Infected Animals

Chronic mastitis cases that do not respond to treatment should be culled. These animals serve as reservoirs for contagious pathogens. Culling decisions should be based on SCC records, culture results, and treatment history.

Vaccination

Vaccines are available for some mastitis pathogens. A 2021 review in the Archives of Razi Institute examined prevention of bovine mastitis through vaccination. The review noted that vaccines against E. coli and Staphylococcus aureus can reduce severity but do not prevent infection entirely. Vaccination should be part of a comprehensive control program.

Biosecurity

Introduce new animals only after testing for mastitis pathogens. Quarantine new arrivals for at least two weeks. Maintain separate equipment for infected and healthy animals. Control visitor access to the milking parlor.

Records and Measurements

Individual Animal Records

Maintain a mastitis log for each animal. Include:

Animal identification number
Date of infection
Quarter affected
Clinical severity score (mild, moderate, severe)
Pathogen identified
Antibiotic used and duration
Milk withdrawal period observed
Outcome (cured, chronic, culled)

Herd-Level Metrics

Track the following metrics monthly:

Bulk tank SCC
Incidence rate of clinical mastitis (cases per 100 cows per month)
Cure rate (percentage of treated cases that resolve)
Culling rate due to mastitis

Benchmarking

Compare herd metrics to regional or national benchmarks. High bulk tank SCC indicates suboptimal udder health. Investigate and address contributing factors.

Common Failure Patterns in Mastitis Management

Incomplete Treatment Courses

Stopping antibiotics early leads to treatment failure and antimicrobial resistance. Always complete the full course as prescribed.

Poor Record Keeping

Without accurate records, it is impossible to identify chronic carriers or track treatment efficacy. Implement a simple record-keeping system.

Inadequate Hygiene

Dirty bedding, contaminated milking equipment, and poor teat preparation increase infection risk. Audit hygiene practices regularly.

Delayed Treatment

Delaying treatment in severe mastitis reduces the chance of recovery. Train staff to recognize clinical signs and initiate treatment promptly.

Ignoring Subclinical Mastitis

Subclinical infections reduce milk production and spread pathogens. Regular SCC monitoring and culture identify these cases.

Welfare and Safety Context

Mastitis causes pain, fever, and systemic illness. Pain management is an essential component of treatment. NSAIDs reduce inflammation and improve comfort. The World Organisation for Animal Health (WOAH) includes mastitis control in its animal health and welfare standards, emphasizing the importance of timely and effective treatment.

Limitations and Professional Escalation Criteria

Limitations of Available Evidence

Many mastitis treatment studies have small sample sizes or lack control groups. A 2019 systematic review in Animal Health Research Reviews noted variability in study designs and outcomes. Clinicians must interpret evidence cautiously and adapt protocols to local conditions.

A 2025 study in BMC Veterinary Research examined treatment strategies and antibiotic usage practices in mastitis management in Kenyan smallholder dairy farms. The study found that many farmers used antibiotics without veterinary guidance, highlighting the need for education and access to diagnostic services.

When to Escalate to a Specialist

Refer to a veterinary specialist or diagnostic laboratory in the following situations:

Mastitis outbreak with high morbidity or mortality
Suspected mycoplasmal mastitis
Recurrent infections in multiple animals
Treatment failure despite appropriate antibiotic selection
Need for advanced diagnostic testing (PCR, genotyping)

Decision Framework for Selecting Mastitis Treatment Based on Pathogen Profile and Herd History

Selecting the appropriate treatment for a mastitis case requires integrating pathogen identification, antimicrobial susceptibility patterns, clinical severity, and individual animal history. A structured decision framework reduces reliance on empirical antibiotic use, improves cure rates, and supports antimicrobial stewardship. The framework presented here is designed for veterinarians and trained herd health managers working with cattle, sheep, and goats.

Tier 1: Pathogen Identification and Susceptibility Profile

The first decision point is determining the causative pathogen. Without culture results, treatment is empirical and carries higher risk of failure. The Merck Veterinary Manual emphasizes that bacteriological culture is the gold standard for mastitis diagnosis. Collect aseptic milk samples from all clinical cases before initiating therapy. For subclinical cases identified through elevated somatic cell counts or positive California Mastitis Test reactions, culture is equally important to guide treatment decisions.

Once the pathogen is identified, antimicrobial susceptibility testing provides the second critical input. A 2011 multispecies review in the Journal of Mammary Gland Biology and Neoplasia noted that susceptibility patterns vary by pathogen, region, and farm. Routine susceptibility testing supports responsible antimicrobial use and improves treatment outcomes. Request minimum inhibitory concentration (MIC) values when available, as these provide more precise guidance than qualitative susceptible-intermediate-resistant categories.

For farms with recurring mastitis problems, compile a herd-specific antibiogram. This document summarizes susceptibility patterns for the most common pathogens isolated on that farm over the previous 12 to 24 months. A herd antibiogram allows veterinarians to select first-line antibiotics with a high probability of efficacy while awaiting individual culture results.

Tier 2: Clinical Severity Classification

Clinical severity determines whether intramammary therapy alone is sufficient or whether systemic antibiotics and supportive care are required. Use a standardized scoring system to classify each case.

Mild clinical mastitis: Abnormal milk with clots, flakes, or discoloration. The udder may be slightly firm but not swollen or painful. The animal is systemically normal with no fever, normal appetite, and normal rumen fill. Intramammary antibiotic therapy is appropriate for mild cases caused by gram-positive pathogens. For mild cases caused by gram-negative pathogens such as Escherichia coli, frequent milk-out and non-steroidal anti-inflammatory drugs may be sufficient without antibiotics, provided the animal remains systemically normal.

Moderate clinical mastitis: Abnormal milk plus visible udder changes including swelling, heat, and pain. The animal remains systemically normal. Intramammary antibiotics are indicated. Consider adding systemic antibiotics if the pathogen is known to cause deep tissue infection, such as Staphylococcus aureus. Non-steroidal anti-inflammatory drugs should be administered to reduce pain and inflammation.

Severe clinical mastitis: Abnormal milk, marked udder swelling, and systemic signs including fever above 39.5 degrees Celsius, depression, anorexia, dehydration, and tachycardia. Systemic antibiotics are mandatory. Intramammary antibiotics may be added but should not replace systemic therapy. Aggressive supportive care including intravenous fluids, non-steroidal anti-inflammatory drugs, and frequent milk-out is critical. A 2024 scoping review in Frontiers in Veterinary Science examined treatment of clinically severe bovine mastitis and highlighted the need for standardized protocols and further research on optimal systemic antibiotic regimens.

Tier 3: Individual Animal History and Chronicity

Before selecting a treatment, review the individual animal's mastitis history. Animals with recurrent infections in the same quarter, persistent subclinical mastitis despite previous treatment, or chronic elevation in somatic cell count are less likely to respond to further antibiotic therapy. A 2019 systematic review and network meta-analysis in Animal Health Research Reviews compared the efficacy of antimicrobials for treatment of clinical mastitis in lactating dairy cattle and found variability in cure rates among different antimicrobial classes. Chronic infections, particularly those caused by Staphylococcus aureus, have low cure rates regardless of antibiotic selection.

For animals with three or more clinical episodes in the same lactation, or with a somatic cell count persistently above 500,000 cells per milliliter despite treatment, culling should be considered. These animals serve as reservoirs for contagious pathogens and contribute to herd-level infection pressure. The World Organisation for Animal Health includes mastitis control in its animal health and welfare standards, emphasizing the importance of removing chronic carriers from the herd.

Tier 4: Treatment Selection Based on Pathogen and Species

Bovine Mastitis Treatment Selection

For Streptococcus agalactiae infections, intramammary antibiotics are highly effective. This pathogen is an obligate intramammary organism with no environmental reservoir, making herd-level eradication achievable. Penicillin-based intramammary products are first-line choices. Treatment duration of two to three days is typically sufficient. Confirm cure with follow-up culture seven to ten days after the end of treatment.

For Staphylococcus aureus infections, treatment success rates are low. Intramammary antibiotics penetrate poorly into microabscesses within the mammary parenchyma. Extended therapy of five to eight days may improve cure rates but remains below 50 percent in most studies. Systemic antibiotics such as ceftiofur or penicillin-streptomycin combinations may be added for deep tissue penetration. Culling chronically infected animals is often the most effective control measure.

For Escherichia coli infections, treatment focuses on supportive care. Intramammary antibiotics are of limited value because the infection is primarily within the milk ducts and cistern, and the bacteria are rapidly cleared by the immune system. Frequent milk-out every two to four hours removes bacteria and endotoxins. Non-steroidal anti-inflammatory drugs reduce inflammation and fever. Systemic antibiotics are indicated only when systemic signs are present. A 2019 systematic review in Animal Health Research Reviews found that antimicrobial treatment of gram-negative mastitis showed variable efficacy, with many cases resolving without antibiotics.

For Mycoplasma species infections, no effective treatment exists. Mycoplasma bovis and other Mycoplasma species are intrinsically resistant to antibiotics that target cell wall synthesis, including penicillins and cephalosporins. Tetracyclines and macrolides may show in vitro activity but clinical cure rates are poor. Control relies on biosecurity, segregation of infected animals, and culling. Diagnosis requires specialized culture media or polymerase chain reaction testing.

Ovine Mastitis Treatment Selection

Ovine mastitis is often acute and severe. Mannheimia haemolytica and Staphylococcus aureus are the most common pathogens. Treatment must be initiated promptly to prevent gangrene and death. Systemic antibiotics are the primary treatment. Oxytetracycline, ceftiofur, and penicillin-streptomycin combinations are commonly used. Selection should be based on culture and sensitivity results. Treatment duration is typically three to five days.

Gangrenous mastitis requires surgical debridement or amputation of the affected udder half. Prognosis is poor, and culling is often recommended.

Caprine Mastitis Treatment Selection

Goat mastitis presents unique challenges. Subclinical infections are common, and somatic cell count thresholds differ from cattle. A somatic cell count above 1,000,000 cells per milliliter in goats suggests infection. Non-aureus staphylococci are the most common pathogens.

A 2025 study in Small Ruminant Research evaluated two long-acting intramammary antimicrobials for curing subclinical mastitis due to non-aureus staphylococci in dairy goats. Cure rates varied by product and pathogen. The study provides evidence that intramammary therapy can be effective for subclinical infections in goats, but treatment decisions should consider cure rates and withdrawal periods.

For severe clinical mastitis in goats, systemic antibiotics are indicated. Ceftiofur, oxytetracycline, and florfenicol are commonly used. A 2016 case-control study in Preventive Veterinary Medicine examined risk factors and therapy for goat mastitis in Bangladesh. The study identified poor hygiene and lack of veterinary care as major risk factors, emphasizing the importance of preventive measures.

Tier 5: Monitoring Treatment Response and Defining Failure

After initiating treatment, monitor the animal daily for clinical improvement. Record rectal temperature, udder appearance, milk appearance, and appetite. For mild and moderate cases, improvement should be evident within 24 to 48 hours. For severe cases, improvement may take 48 to 72 hours.

Define treatment failure as:

No improvement in clinical signs after 48 hours of appropriate therapy
Worsening of clinical signs at any point during treatment
Recurrence of clinical signs within 14 days of completing treatment
Positive bacteriological culture at follow-up sampling seven to ten days after treatment completion

When treatment failure occurs, re-culture the affected quarter and perform antimicrobial susceptibility testing. Consider the possibility of mixed infections, abscess formation, or infection with a resistant pathogen. Escalate to a veterinary specialist if treatment failure persists.

Record System for Treatment Decisions and Outcomes

A structured record system supports evidence-based treatment decisions and allows evaluation of herd-level treatment efficacy. Maintain the following records for each mastitis case.

Individual animal treatment record:

Animal identification number
Date of diagnosis
Quarter affected
Clinical severity score (mild, moderate, severe)
Pathogen identified
Antimicrobial susceptibility results
Antibiotic selected and dose
Treatment duration
Supportive therapies administered
Milk withdrawal period observed
Clinical outcome at 48 hours, 7 days, and 14 days
Bacteriological cure status (if follow-up culture performed)
Recurrence within same lactation

Herd-level treatment summary:

Monthly clinical mastitis incidence rate (cases per 100 animals)
Pathogen distribution (percentage of cases caused by each pathogen)
Antimicrobial susceptibility patterns by pathogen
Clinical cure rate (percentage of cases that resolve clinically)
Bacteriological cure rate (percentage of cases with negative follow-up culture)
Treatment failure rate
Recurrence rate
Culling rate due to mastitis

Review these metrics quarterly with the herd veterinarian. Identify trends such as increasing treatment failure rates, emergence of resistant pathogens, or changes in pathogen distribution. Adjust treatment protocols and control measures accordingly.

Common Failure Patterns in Treatment Decision-Making

Empirical antibiotic selection without culture: Choosing antibiotics based on habit instead of pathogen identification leads to inappropriate therapy and contributes to antimicrobial resistance. A 2025 study in BMC Veterinary Research examined treatment strategies and antibiotic usage practices in mastitis management in Kenyan smallholder dairy farms. The study found that many farmers used antibiotics without veterinary guidance, highlighting the need for education and access to diagnostic services.

Inadequate treatment duration: Stopping antibiotics early because the milk appears normal leads to incomplete bacterial clearance and recurrence. Complete the full course as prescribed, even if clinical signs resolve.

Ignoring susceptibility results: Using an antibiotic to which the pathogen is resistant guarantees treatment failure. Always review susceptibility results before selecting therapy.

Treating chronic infections repeatedly: Animals with chronic Staphylococcus aureus infections or multiple recurrences have low cure rates. Repeated treatment exposes the animal to unnecessary antibiotics and delays culling decisions. Set a maximum number of treatments per lactation and adhere to it.

Delaying treatment in severe cases: Severe mastitis requires immediate systemic antibiotics and supportive care. Delaying treatment while waiting for culture results reduces the chance of recovery. In severe cases, initiate broad-spectrum systemic antibiotics immediately and adjust based on culture results.

Welfare and Safety Context for Treatment Decisions

Mastitis causes pain, fever, and systemic illness. Pain management is an essential component of treatment. Non-steroidal anti-inflammatory drugs reduce inflammation and improve comfort. The World Organisation for Animal Health includes mastitis control in its animal health and welfare standards, emphasizing the importance of timely and effective treatment.

Antimicrobial resistance is a growing concern. Responsible antibiotic use preserves efficacy for future cases. Base treatment decisions on culture and sensitivity results whenever possible. Follow label instructions for dosage and withdrawal periods. Never use antibiotics that are critically important for human medicine, such as third-generation cephalosporins and fluoroquinolones, as first-line treatments.

Limitations and Professional Escalation Criteria

Refer to a veterinary specialist or diagnostic laboratory in the following situations:

Mastitis outbreak with high morbidity or mortality
Suspected mycoplasmal mastitis
Recurrent infections in multiple animals
Treatment failure despite appropriate antibiotic selection based on susceptibility results
Need for advanced diagnostic testing such as polymerase chain reaction or genotyping
Herd-level somatic cell count above 400,000 cells per milliliter in cattle or above 1,000,000 cells per milliliter in goats despite implementation of control measures

Decision Framework for Selecting Mastitis Treatment Based on Pathogen Profile and Herd History

Tier 1: Pathogen Identification and Susceptibility Profile

Tier 2: Clinical Severity Classification

Tier 3: Individual Animal History and Chronicity

Tier 4: Treatment Selection Based on Pathogen and Species

Bovine Mastitis Treatment Selection

Ovine Mastitis Treatment Selection

Gangrenous mastitis requires surgical debridement or amputation of the affected udder half. Prognosis is poor, and culling is often recommended.

Caprine Mastitis Treatment Selection

Tier 5: Monitoring Treatment Response and Defining Failure

Define treatment failure as:

No improvement in clinical signs after 48 hours of appropriate therapy
Worsening of clinical signs at any point during treatment
Recurrence of clinical signs within 14 days of completing treatment
Positive bacteriological culture at follow-up sampling seven to ten days after treatment completion

Record System for Treatment Decisions and Outcomes

A structured record system supports evidence-based treatment decisions and allows evaluation of herd-level treatment efficacy. Maintain the following records for each mastitis case.

Individual animal treatment record:

Animal identification number
Date of diagnosis
Quarter affected
Clinical severity score (mild, moderate, severe)
Pathogen identified
Antimicrobial susceptibility results
Antibiotic selected and dose
Treatment duration
Supportive therapies administered
Milk withdrawal period observed
Clinical outcome at 48 hours, 7 days, and 14 days
Bacteriological cure status (if follow-up culture performed)
Recurrence within same lactation

Herd-level treatment summary:

Monthly clinical mastitis incidence rate (cases per 100 animals)
Pathogen distribution (percentage of cases caused by each pathogen)
Antimicrobial susceptibility patterns by pathogen
Clinical cure rate (percentage of cases that resolve clinically)
Bacteriological cure rate (percentage of cases with negative follow-up culture)
Treatment failure rate
Recurrence rate
Culling rate due to mastitis

Common Failure Patterns in Treatment Decision-Making

Ignoring susceptibility results: Using an antibiotic to which the pathogen is resistant guarantees treatment failure. Always review susceptibility results before selecting therapy.

Welfare and Safety Context for Treatment Decisions

Limitations and Professional Escalation Criteria

Refer to a veterinary specialist or diagnostic laboratory in the following situations:

Mastitis outbreak with high morbidity or mortality
Suspected mycoplasmal mastitis
Recurrent infections in multiple animals
Treatment failure despite appropriate antibiotic selection based on susceptibility results
Need for advanced diagnostic testing such as polymerase chain reaction or genotyping
Herd-level somatic cell count above 400,000 cells per milliliter in cattle or above 1,000,000 cells per milliliter in goats despite implementation of control measures

Frequently Asked Questions

What is the difference between clinical and subclinical mastitis?

Clinical mastitis shows visible signs such as swollen udder, abnormal milk, and systemic illness. Subclinical mastitis has no visible signs but is detected through elevated somatic cell counts and bacteriological culture. Both forms reduce milk production and require management.

How is mastitis diagnosed in ruminants?

Diagnosis begins with clinical examination and milk sample collection. The California Mastitis Test provides a rapid screening. Bacteriological culture identifies the causative pathogen. Antimicrobial susceptibility testing guides treatment selection. Somatic cell count monitoring tracks udder health over time.

What antibiotics are used for mastitis treatment?

Antibiotic selection depends on the pathogen and susceptibility results. Intramammary antibiotics are standard for uncomplicated cases. Systemic antibiotics are indicated for severe infections with systemic signs. Always follow label instructions and observe withdrawal periods.

Can mastitis be treated without antibiotics?

Mild cases may resolve with frequent milk-out and supportive care. However, antibiotics are necessary for most bacterial infections. A 2018 study in The Veterinary Record found that antibiotics were more effective than homeopathy for clinical cure. Alternative therapies lack robust evidence for severe cases.

How can mastitis be prevented at the herd level?

Prevention focuses on milking hygiene, dry cow therapy, culling chronic carriers, vaccination, and biosecurity. Regular SCC monitoring and bacteriological culture identify problem areas. The World Organisation for Animal Health (WOAH) provides standards for mastitis control.

What is the prognosis for mastitis in sheep?

Prognosis depends on the pathogen and timeliness of treatment. Mannheimia haemolytica causes gangrenous mastitis with a poor prognosis. Early systemic antibiotics and supportive care improve outcomes. Culling is often recommended for severe or recurrent cases.

How is mastitis managed in goats?

Goat mastitis management includes intramammary and systemic antibiotics, supportive care, and culling chronic carriers. Subclinical infections are common and require regular SCC monitoring. A 2025 study in Small Ruminant Research evaluated long-acting intramammary antimicrobials for non-aureus staphylococci in goats.

When should a veterinarian be called for mastitis?

Call a veterinarian for severe clinical mastitis with systemic signs, suspected mycoplasmal infection, treatment failure, or herd outbreaks. A veterinarian can perform diagnostic testing, prescribe appropriate antibiotics, and develop a herd-level control plan.

Related Veterinary Guides

References and Further Reading

www.acvim.org
Merck Veterinary Manual. Merck Veterinary Manual.
Animal Health and Welfare. World Organisation for Animal Health.
Treatment of clinically severe bovine mastitis - a scoping review.. Frontiers in veterinary science, 2024.
Prevention of Bovine Mastitis through Vaccination.. Archives of Razi Institute, 2021.
Comparative effectiveness of individualised homeopathy and antibiotics in the treatment of bovine clinical mastitis: randomised controlled trial.. The Veterinary record, 2018.
Comparative efficacy of antimicrobials for treatment of clinical mastitis in lactating dairy cattle: a systematic review and network meta-analysis.. Animal health research reviews, 2019.
Treatment strategies and antibiotic usage practices in mastitis management in Kenyan smallholder dairy farms.. BMC veterinary research, 2025.
Management of mastitis on organic and conventional dairy farms.. Journal of animal science, 2009.
Risk factors and therapy for goat mastitis in a hospital-based case-control study in Bangladesh. Preventive Veterinary Medicine, 2016.
Efficacy of two long-acting intramammary antimicrobials for curing subclinical mastitis due to non-aureus staphylococci in dairy goats. Small Ruminant Research, 2025.
Mastitis therapy and antimicrobial susceptibility: A multispecies review with a focus on antibiotic treatment of mastitis in dairy cattle. Journal of Mammary Gland Biology and Neoplasia, 2011.
Conventional and alternative treatment of mastitis in dairy goats. Small Ruminant Research, 2025.

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.